TrialBMC infectious diseases2023

Helicobacter pylori eradication rates using clarithromycin and levofloxacin-based regimens in patients with previous COVID-19 treatment: a randomized clinical trial.

Ahmed Kamal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.